Human papillomavirus infection and expression of p53 and c-erbB-2 protein in laryngeal papillomas

Acta Oto-Laryngologica, Supplement

Volumn , Issue 527, 1997, Pages 120-124

  Luzar, Boštjan ^a   Gale, Nina ^a   Kambič, Vinko ^a   Poljak, Mario ^a   Zidar, Nina ^a   Vodovnik, Aleksandar ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

c erbB 2 protein; HPV infection; human papillomavirus; laryngeal papillomas; p53 protein

Indexed keywords

PROTEIN P53; EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ARTICLE; CANCER RISK; DIAGNOSTIC VALUE; GENE AMPLIFICATION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LARYNX PAPILLOMATOSIS; PRIORITY JOURNAL; WART VIRUS; CHEMISTRY; ENZYME IMMUNOASSAY; EPITHELIUM; HYPERPLASIA; LARYNX; LARYNX TUMOR; METABOLISM; PAPILLOMA; PAPILLOMA VIRUS; PATHOLOGY; RETROSPECTIVE STUDY; VIROLOGY; VIRUS INFECTION;

EPITHELIUM; HUMANS; HYPERPLASIA; IMMUNOENZYME TECHNIQUES; LARYNGEAL NEOPLASMS; LARYNX; PAPILLOMA; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RECEPTOR, ERBB-2; RETROSPECTIVE STUDIES; TUMOR SUPPRESSOR PROTEIN P53; TUMOR VIRUS INFECTIONS;

EID: 0030611141     PISSN: 03655237     EISSN: None     Source Type: Journal    
DOI: 10.3109/00016489709124052     Document Type: Article

References (20)

1. Chang F, Wang L, Syrjänen S, Syrjänen H. Human papillomavirus infections in the respiratory tract. Am J Otolaryngol 1992; 13: 210-25.
2. Kambič V, Gale N. Epithelial hyperplastic lesions of the larynx. Amsterdam: Elsevier, 1995.
3. Yoder MG, Batsakis JG. Squamous cell carcinoma in solitary laryngeal papilloma. Arch Otolaryngol Head Neck Surg 1980; 88: 745-8.
4. Majores M, Parkhill EM, Devine KD. Malignant transformation of benign laryngeal papillomas in children after radiation therapy. Surg Clin North Am 1963; 43: 1049-61.
5. Lindeberg H, Elbrond O. Laryngeal papillomas: clinical aspects in a series of 231 patients. Clin Otolaryngol 1989; 14: 333-42.
6. Semba K, Kamata N, Toyoshima K, Yamamoto T. A v-erbB related protooncogene, c-erbB-2, is distinct from the c-erbB-1-epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma. Proc Natl Acad Sci USA 1985; 82: 6497-501.
7. Field JK, Spandidos DA, Yiagnisis M, Gosney JR, Papadimitriou K, Stell PM. c-erbB-2 expression in squamous cell carcinoma of the head and neck. Anticancer Res 1992; 12: 613-20.
8. Bacus SS, Zelnick CR, Plowman G, Yarden Y. Expression of the erbB-2 family of growth factor receptors and their ligands in breast cancers. Am J Clin Pathol 1994; 102(Suppl 1): 13-24.
9. Underwood M, Bartlett J, Reeves J, Gardiner DS, Scott R, Cooke T. c-erbB-2 gene amplification: a molecular marker in recurrent bladder tumors? Cancer Res 1955; 55: 2422-30.
10. Chow NH, Huang SM, Chan SH, Mo LR, Hwang MH, Su WC. Significance of c-erbB-2 expression in normal and neoplastic epithelium of biliary tract. Anticancer Res 1995; 15: 1055-60.
11. Kambič V, Lenart I. Notre classification des hyperplasies de l'épithélium du larynx au point de vue pronostic. JFORL 1971; 20: 1145-50.
12. Poljak M, Orlowska J, Cerar A. Human papillomavirus infection in esophageal squamous cell papillomas: a study of 29 lesions. Anticancer Res 1995; 15: 965-70.
13. Werness BA, Arnold JL, Howley PM. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 1990; 248: 76-9.
14. Scheffner M, Werness BA, Huibregtse JM, Howley PM. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 1990; 63: 1129-36.
15. Li X, Coffino Ph. High-risk human papillomavirus E6 protein has two distinct binding sites within p53, of which only one determines degradation. J Virol 1996; 70: 4509-16.
16. Fouret P, Dabit D, Sibony M, Alili D, Commo F, Saint-Guily LJ, et al. Expression of p53 protein related to the presence of human papillomavirus infection in precancer lesions of the larynx. Am J Pathol 1995; 146: 599-604.
17. Hall P, Lane DP. p53 in tumour pathology: can we trust immunohistochemistry? Revisited! J Pathol 1994; 172: 1-4.
18. Barnes DM, Handby AM, Gillett CE. Abnormal expression of wild-type p53 protein in normal cell of cancer family patient. Lancet 1992; 340: 259-63.
19. De Potter CR, Quatacker J, Maertens G, Van Daele S, Pauwels C, Verhofstede C, et al. The subcellular localisation of the neu protein in human normal and neoplastic cells. Int J Cancer 1989; 44: 969-74.
20. Gusterson BA, Machin LG, Gullick WJ, et al. c-erbB-2 expression in benign and malignant breast diseases. Br J Cancer 1988; 58: 453-57.